Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis

Nutr Res. 2016 Oct;36(10):1105-1113. doi: 10.1016/j.nutres.2016.06.008. Epub 2016 Jun 14.

Abstract

The nutritional prevention of aberrant crypt foci by polyphenols may be a crucial step to dietary cancer prevention. The objective of this study was to determine the underlying mechanisms that contribute to the anti-inflammatory and antitumorigenic properties of plum (Prunus salicina L.) polyphenols, including chlorogenic acid and neochlorogenic acid, in azoxymethane (AOM)-treated rats. The hypothesis was that plum polyphenolics suppress AOM-induced aberrant crypt foci formation through alterations in the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and relative micro-RNA expressions. Sprague-Dawley rats (n=10/group) received plum beverage (1346mg gallic acid equivalents/L) or a control beverage ad libitum for 10 weeks with subcutaneous injections of AOM (15mg/kg) at weeks 2 and 3. Results show that the consumption of the plum beverage decreased the number of dysplastic aberrant crypt foci by 48% (P<.05) and lowered proliferation of mucosal cells by 24% (P<.05). The plum beverage decreased the activity of glutathione peroxidase, superoxide dismutase, and catalase in mucosal scrapings, as well as the superoxide dismutase activity in serum. The results were accompanied by a down-regulation of proinflammatory enzymes nuclear factor κB, nitric oxide synthase, cyclooxygenase-2, and vascular cell adhesion molecule 1 messenger RNA. Plum inhibited the expression of AKT and mTOR messenger RNA, phosphorylated AKT, mTOR, and hypoxia-inducible factor-1α protein levels, and the ratio of the phosphorylated/total protein expression of mTOR. Also, the plum beverage increased the expression of miR-143, which is involved in the regulation of AKT. These results suggest that plum polyphenols may exhibit a chemopreventive potential against colon carcinogenesis by impacting the AKT/mTOR pathway and miR-143.

Keywords: Chlorogenic acid; Colon cancer; Inflammation; Plum; Rat; mTOR; miR-143.

MeSH terms

  • Aberrant Crypt Foci / chemically induced
  • Aberrant Crypt Foci / prevention & control*
  • Animals
  • Anticarcinogenic Agents / pharmacology
  • Anticarcinogenic Agents / therapeutic use
  • Azoxymethane
  • Cell Proliferation
  • Chlorogenic Acid / analogs & derivatives
  • Chlorogenic Acid / pharmacology
  • Chlorogenic Acid / therapeutic use
  • Colon / drug effects
  • Colon / pathology
  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / prevention & control
  • Diet
  • Inflammation Mediators / metabolism
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Male
  • MicroRNAs / metabolism*
  • Phosphorylation
  • Plant Extracts / pharmacology
  • Polyphenols / pharmacology*
  • Polyphenols / therapeutic use
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Prunus domestica / chemistry*
  • Quinic Acid / analogs & derivatives
  • Quinic Acid / pharmacology
  • Quinic Acid / therapeutic use
  • Rats, Sprague-Dawley
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Anticarcinogenic Agents
  • Inflammation Mediators
  • MIRN143 microRNA, rat
  • MicroRNAs
  • Plant Extracts
  • Polyphenols
  • Quinic Acid
  • Chlorogenic Acid
  • mTOR protein, rat
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Azoxymethane
  • 5'-O-caffeoylquinic acid